Active Ingredient History
Dehydroepiandrosterone (INTRAROSA™, prasterone) is a major C19 steroid produced from cholesterol by the adrenal cortex. It is also produced in small quantities in the testis and the ovary. Dehydroepiandrosterone (INTRAROSA, prasterone) is structurally similar to, and is a precursor of, androstenedione, testosterone, estradiol, estrone and estrogen. It indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. The mechanism of action of dehydroepiandrosterone (INTRAROSA, prasterone) in postmenopausal women with vulvar and vaginal atrophy is not fully established. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 4)
Dyspareunia (Phase 4)
Fertilization in Vitro (Phase 3)
Genital Neoplasms, Female (Phase 3)
Hormone Replacement Therapy (Phase 3)
Infertility (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Menopause (Phase 4)
Multiple Myeloma (Phase 2)
Ovarian Diseases (Phase 2/Phase 3)
Postmenopause (Phase 3)
Primary Ovarian Insufficiency (Phase 2/Phase 3)
Sexual Dysfunctions, Psychological (Phase 3)
Urinary Tract Infections (Phase 3)
Vaginal Diseases (Phase 3)
Vulvar Diseases (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
